Logo image of TIRX

TIAN RUIXIANG HOLDINGS LTD-A (TIRX) Stock Fundamental Analysis

NASDAQ:TIRX - Nasdaq - KYG8884K1287 - Common Stock - Currency: USD

0.88  -0.07 (-7.37%)

After market: 0.8686 -0.01 (-1.3%)

Fundamental Rating

3

TIRX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 143 industry peers in the Insurance industry. While TIRX has a great health rating, there are worries on its profitability. TIRX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year TIRX has reported negative net income.
In the past year TIRX had a positive cash flow from operations.
TIRX had negative earnings in 4 of the past 5 years.
In multiple years TIRX reported negative operating cash flow during the last 5 years.
TIRX Yearly Net Income VS EBIT VS OCF VS FCFTIRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M

1.2 Ratios

With a Return On Assets value of -9.97%, TIRX is not doing good in the industry: 91.61% of the companies in the same industry are doing better.
TIRX's Return On Equity of -11.76% is on the low side compared to the rest of the industry. TIRX is outperformed by 88.81% of its industry peers.
Industry RankSector Rank
ROA -9.97%
ROE -11.76%
ROIC N/A
ROA(3y)-10.09%
ROA(5y)-5.76%
ROE(3y)-11.11%
ROE(5y)-6.19%
ROIC(3y)N/A
ROIC(5y)N/A
TIRX Yearly ROA, ROE, ROICTIRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TIRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TIRX Yearly Profit, Operating, Gross MarginsTIRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

7

2. Health

2.1 Basic Checks

TIRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
TIRX has more shares outstanding than it did 1 year ago.
TIRX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TIRX is higher compared to a year ago.
TIRX Yearly Shares OutstandingTIRX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
TIRX Yearly Total Debt VS Total AssetsTIRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 11.84 indicates that TIRX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 11.84, TIRX belongs to the best of the industry, outperforming 98.60% of the companies in the same industry.
The Debt to FCF ratio of TIRX is 1.25, which is an excellent value as it means it would take TIRX, only 1.25 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.25, TIRX is in line with its industry, outperforming 56.64% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that TIRX is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.00, TIRX belongs to the best of the industry, outperforming 88.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.25
Altman-Z 11.84
ROIC/WACCN/A
WACC7.5%
TIRX Yearly LT Debt VS Equity VS FCFTIRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

TIRX has a Current Ratio of 6.74. This indicates that TIRX is financially healthy and has no problem in meeting its short term obligations.
TIRX has a Current ratio of 6.74. This is amongst the best in the industry. TIRX outperforms 100.00% of its industry peers.
TIRX has a Quick Ratio of 6.74. This indicates that TIRX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 6.74, TIRX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.74
Quick Ratio 6.74
TIRX Yearly Current Assets VS Current LiabilitesTIRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

TIRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.50%, which is quite impressive.
Looking at the last year, TIRX shows a very strong growth in Revenue. The Revenue has grown by 158.72%.
TIRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.96% yearly.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.7%
Revenue 1Y (TTM)158.72%
Revenue growth 3Y4.88%
Revenue growth 5Y9.96%
Sales Q2Q%485.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TIRX Yearly Revenue VS EstimatesTIRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TIRX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TIRX Price Earnings VS Forward Price EarningsTIRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

76.92% of the companies in the same industry are cheaper than TIRX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 119.38
EV/EBITDA N/A
TIRX Per share dataTIRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TIRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TIAN RUIXIANG HOLDINGS LTD-A

NASDAQ:TIRX (8/8/2025, 8:09:04 PM)

After market: 0.8686 -0.01 (-1.3%)

0.88

-0.07 (-7.37%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)10-27 2022-10-27/amc
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap107.19M
Analysts0
Price TargetN/A
Short Float %0.06%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 33.3
P/FCF 119.38
P/OCF 119.38
P/B 3.16
P/tB 3.16
EV/EBITDA N/A
EPS(TTM)-2.42
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY0.84%
OCF(TTM)0.01
OCFY0.84%
SpS0.03
BVpS0.28
TBVpS0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.97%
ROE -11.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 27.89%
ROA(3y)-10.09%
ROA(5y)-5.76%
ROE(3y)-11.11%
ROE(5y)-6.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.25
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.74
Quick Ratio 6.74
Altman-Z 11.84
F-Score4
WACC7.5%
ROIC/WACCN/A
Cap/Depr(3y)3.49%
Cap/Depr(5y)7.09%
Cap/Sales(3y)0.06%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)158.72%
Revenue growth 3Y4.88%
Revenue growth 5Y9.96%
Sales Q2Q%485.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-9.7%
FCF growth 3YN/A
FCF growth 5Y92.46%
OCF growth 1Y-9.7%
OCF growth 3YN/A
OCF growth 5Y31.41%